{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:13:16Z","timestamp":1770354796975,"version":"3.49.0"},"publisher-location":"Berlin, Heidelberg","reference-count":101,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540790891","type":"print"},{"value":"9783540790907","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-79090-7_3","type":"book-chapter","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T16:35:28Z","timestamp":1249403728000},"page":"75-89","source":"Crossref","is-referenced-by-count":15,"title":["Migraine"],"prefix":"10.1007","author":[{"given":"Silvia","family":"Benemei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay G.","family":"Capone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco De","family":"Cesaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"3_CR1_3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38815-9","volume":"296","author":"N Aiyar","year":"2001","unstructured":"Aiyar N, Daines RA, Disa J et al (2001) Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 296:768\u2013775","journal-title":"J Pharmacol Exp Ther"},{"key":"3_CR2_3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0896-6273(03)00462-8","volume":"39","author":"N Alessandri-Haber","year":"2003","unstructured":"Alessandri-Haber N, Yeh JJ, Boyd AE et al (2003) Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 39:497\u2013511","journal-title":"Neuron"},{"key":"3_CR3_3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.2994212","volume":"229","author":"SG Amara","year":"1985","unstructured":"Amara SG, Arriza JL, Leff SE et al (1985) Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094\u20131097","journal-title":"Science"},{"key":"3_CR4_3","first-page":"L263","volume":"268","author":"P Baluk","year":"1995","unstructured":"Baluk P, Bertrand C, Geppetti P et al (1995) NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 268:L263\u2013L269","journal-title":"Am J Physiol"},{"key":"3_CR5_3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(04)00150-3","volume":"41","author":"M Bandell","year":"2004","unstructured":"Bandell M, Story GM, Hwang SW et al (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41:849\u2013857","journal-title":"Neuron"},{"key":"3_CR6_3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","volume":"124","author":"DM Bautista","year":"2006","unstructured":"Bautista DM, Jordt SE, Nikai T et al (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269\u20131282","journal-title":"Cell"},{"key":"3_CR7_3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature05910","volume":"448","author":"DM Bautista","year":"2007","unstructured":"Bautista DM, Siemens J, Glazer JM et al (2007) The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448:204\u2013208","journal-title":"Nature"},{"key":"3_CR8_3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0166-2236(94)90149-X","volume":"17","author":"S Bevan","year":"1994","unstructured":"Bevan S, Geppetti P (1994) Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 17:509\u2013512","journal-title":"Trends Neurosci"},{"key":"3_CR9_3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/jm061343w","volume":"50","author":"D Boeglin","year":"2007","unstructured":"Boeglin D, Hamdan FF, Melendez RE et al (2007) Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. J Med Chem 50:1401\u20131408","journal-title":"J Med Chem"},{"key":"3_CR10_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1989.tb11926.x","volume":"97","author":"SD Brain","year":"1989","unstructured":"Brain SD, Williams TJ (1989) Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol 97:77\u201382","journal-title":"Br J Pharmacol"},{"key":"3_CR11_3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","volume":"313","author":"SD Brain","year":"1985","unstructured":"Brain SD, Williams TJ, Tippins JR et al (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54\u201356","journal-title":"Nature"},{"key":"3_CR12_3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1212\/WNL.7.1.52","volume":"7","author":"P Brazil","year":"1957","unstructured":"Brazil P, Friedman A (1957) Further observations in craniovascular studies. Neurology 7:52\u201355","journal-title":"Neurology"},{"key":"3_CR13_3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","volume":"389","author":"MJ Caterina","year":"1997","unstructured":"Caterina MJ, Schumacher MA, Tominaga M et al (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816\u2013824","journal-title":"Nature"},{"key":"3_CR14_3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/18906","volume":"398","author":"MJ Caterina","year":"1999","unstructured":"Caterina MJ, Rosen TA, Tominaga M et al (1999) A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398:436\u2013441","journal-title":"Nature"},{"key":"3_CR15_3","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.1989.256.2.E331","volume":"256","author":"T Chiba","year":"1989","unstructured":"Chiba T, Yamaguchi A, Yamatani T et al (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8\u201337). Am J Physiol Endocrinol Metab 256:E331\u2013E335","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3_CR16_3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/35082088","volume":"411","author":"HH Chuang","year":"2001","unstructured":"Chuang HH, Prescott ED, Kong H et al (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957\u2013962","journal-title":"Nature"},{"key":"3_CR17_3","first-page":"392","volume":"18","author":"H Connor","year":"1998","unstructured":"Connor H, Bertin L, Gillies S et al (1998) The GR205171 clinical study group. Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine. Cephalalgia 18:392","journal-title":"Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine. Cephalalgia"},{"key":"3_CR18_3","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJS Cooper","year":"1987","unstructured":"Cooper GJS, Willis AC, Clark A et al (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628\u20138632","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR19_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-2982.2003.00496.x","volume":"23","author":"HC Diener","year":"2003","unstructured":"Diener HC (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23:183\u2013185","journal-title":"Cephalalgia"},{"key":"3_CR20_3","first-page":"1261","volume":"2","author":"H Doods","year":"2001","unstructured":"Doods H (2001) Development of CGRP antagonists for the treatment of migraine. Curr Opin Investig Drugs 2:1261\u20131268","journal-title":"Curr Opin Investig Drugs"},{"key":"3_CR21_3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","volume":"129","author":"H Doods","year":"2000","unstructured":"Doods H, Hallermayer G, Wu D et al (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420\u2013423","journal-title":"Br J Pharmacol"},{"key":"3_CR22_3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","volume":"28","author":"H Doods","year":"2007","unstructured":"Doods H, Arndt K, Rudolf K et al (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580\u2013587","journal-title":"Trends Pharmacol Sci"},{"key":"3_CR23_3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMp048016","volume":"350","author":"PL Durham","year":"2004","unstructured":"Durham PL (2004) CGRP-receptor antagonists \u2013 a fresh approach to migraine therapy? New Engl J Med 350:1073\u20131075","journal-title":"New Engl J Med"},{"key":"3_CR24_3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1468-2982.2003.00719.x","volume":"24","author":"L Edvinsson","year":"2004","unstructured":"Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24:611\u2013622","journal-title":"Cephalalgia"},{"key":"3_CR25_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00934-1","volume":"415","author":"L Edvinsson","year":"2001","unstructured":"Edvinsson L, Sams A, Jansen-Olesen I et al (2001) Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 415:39\u201344","journal-title":"Eur J Pharmacol"},{"key":"3_CR26_3","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/jm980137o","volume":"41","author":"MD Ennis","year":"1998","unstructured":"Ennis MD, Ghazal NB, Hoffman RL et al (1998) Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects. J Med Chem 41:2180\u20132183","journal-title":"J Med Chem"},{"key":"3_CR27_3","doi-asserted-by":"crossref","first-page":"PL27","DOI":"10.1016\/0024-3205(91)90263-B","volume":"49","author":"M Fanciullacci","year":"1991","unstructured":"Fanciullacci M, Tramontana M, Bianco ED et al (1991) Low pH medium induces calcium dependent release of CGRP from sensory nerves of guinea-pig dural venous sinuses. Life Sci 49:PL27\u2013PL30","journal-title":"Life Sci"},{"key":"3_CR28_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M et al (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119\u2013123","journal-title":"Pain"},{"key":"3_CR29_3","first-page":"74","volume":"62","author":"T Fay","year":"1935","unstructured":"Fay T (1935) The mechanism of headache. Trans Am Neurol Assoc 62:74\u201377","journal-title":"Trans Am Neurol Assoc"},{"key":"3_CR30_3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.10.6.555","volume":"10","author":"W Feindel","year":"1960","unstructured":"Feindel W, Penfield W, Mc NF (1960) The tentorial nerves and localization of intracranial pain in man. Neurology 10:555\u2013563","journal-title":"Neurology"},{"key":"3_CR31_3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.RES.87.8.670","volume":"87","author":"C Fernandez-Patron","year":"2000","unstructured":"Fernandez-Patron C, Stewart KG, Zhang Y et al (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87:670\u2013676","journal-title":"Circ Res"},{"key":"3_CR32_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1468-2982.1993.1303151.x","volume":"13","author":"MD Ferrari","year":"1993","unstructured":"Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151\u2013165","journal-title":"Cephalalgia"},{"key":"3_CR33_3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","volume":"358","author":"MD Ferrari","year":"2001","unstructured":"Ferrari MD, Roon KI, Lipton RB et al (2001) Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668\u20131675","journal-title":"Lancet"},{"key":"3_CR34_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1995.1047","volume":"206","author":"B Fluhmann","year":"1995","unstructured":"Fluhmann B, Muff R, Hunziker W et al (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206:341\u2013347","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR35_3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1476-5381.1991.tb12201.x","volume":"102","author":"A Franco-Cereceda","year":"1991","unstructured":"Franco-Cereceda A (1991) Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects. Br J Pharmacol 102:506\u2013510","journal-title":"Br J Pharmacol"},{"key":"3_CR36_3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.freeradbiomed.2007.05.018","volume":"43","author":"D Gazzieri","year":"2007","unstructured":"Gazzieri D, Trevisani M, Springer J et al (2007) Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med. 43:581\u2013589","journal-title":"Free Radic Biol Med."},{"key":"3_CR37_3","volume-title":"Neurogenic inflammation","author":"P Geppetti","year":"1996","unstructured":"Geppetti P, Holzer P (1996) Neurogenic inflammation. CRC, Boca Raton"},{"key":"3_CR38_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-0115(92)90516-W","volume":"41","author":"P Geppetti","year":"1992","unstructured":"Geppetti P, Del Bianco E, Cecconi R et al (1992) Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro. Regul Pept 41:83\u201392","journal-title":"Regul Pept"},{"key":"3_CR39_3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1468-2982.2003.00511.x","volume":"23","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Kowacs F, Libri V et al (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287\u2013292","journal-title":"Cephalalgia"},{"key":"3_CR40_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"3_CR41_3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD (2002a) Migraine \u2013 current understanding and treatment. New Engl J Med 346:257\u2013270","journal-title":"New Engl J Med"},{"key":"3_CR42_3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/brain\/awf141","volume":"125","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Hoskin KL, Storer RJ et al (2002b) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392\u20131401","journal-title":"Brain"},{"key":"3_CR43_3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","volume":"17","author":"DJ Goldstein","year":"1997","unstructured":"Goldstein DJ, Wang O, Saper JR et al (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785\u2013790","journal-title":"Cephalalgia"},{"key":"3_CR44_3","first-page":"318","volume":"19","author":"J Goldstein","year":"1999","unstructured":"Goldstein J, Roon I, Offen W et al (1999) Migraine treatment with selective with 5-ht1F receptor agonist (SSOFRA) LY334370. Cephalalgia 19:318","journal-title":"Cephalalgia"},{"key":"3_CR45_3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1468-2982.2001.00208.x","volume":"21","author":"B Gomez-Mancilla","year":"2001","unstructured":"Gomez-Mancilla B, Cutler N, Leibowitz M et al (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727\u2013732","journal-title":"Cephalalgia"},{"key":"3_CR46_3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archneurpsyc.1938.02270040093005","volume":"39","author":"J Graham","year":"1938","unstructured":"Graham J, Wolff H (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737\u2013763","journal-title":"Arch Neurol Psychiatry"},{"key":"3_CR47_3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1476-5381.1992.tb14508.x","volume":"107","author":"DW Gray","year":"1992","unstructured":"Gray DW, Marshall I (1992) Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107:691\u2013696","journal-title":"Br J Pharmacol"},{"key":"3_CR48_3","first-page":"1304","volume":"70","author":"TW Ho","year":"2007","unstructured":"Ho TW, Mannix LK, Fan X et al (2007) Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304\u20131312","journal-title":"Neurology"},{"key":"3_CR49_3","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","volume":"99","author":"SM Huang","year":"2002","unstructured":"Huang SM, Bisogno T, Trevisani M et al (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400\u20138405","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR50_3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/0333102401021s0102","volume":"21","author":"PP Humphrey","year":"2001","unstructured":"Humphrey PP, Bland-Ward PA, Carruthers AM et al (2001) Inhibition of trigemnial nociceptive afferents by adenosine A1 receptor activation: a novel approach towards the design of new anti-migraine compounds. Cephalalgia 21:268\u2013269","journal-title":"Cephalalgia"},{"key":"3_CR51_3","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","volume":"97","author":"SW Hwang","year":"2000","unstructured":"Hwang SW, Cho H, Kwak J et al (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155\u20136156","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR52_3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","volume":"427","author":"SE Jordt","year":"2004","unstructured":"Jordt SE, Bautista DM, Chuang HH et al (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427:260\u2013265","journal-title":"Nature"},{"key":"3_CR53_3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","volume":"106","author":"G Juhasz","year":"2003","unstructured":"Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461\u2013470","journal-title":"Pain"},{"key":"3_CR54_3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bjp.0705451","volume":"140","author":"K Kapoor","year":"2003","unstructured":"Kapoor K, Arulmani U, Heiligers JPC et al (2003) Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol 140:329\u2013338","journal-title":"Br J Pharmacol"},{"key":"3_CR55_3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","volume":"192","author":"K Kitamura","year":"1993","unstructured":"Kitamura K, Kangawa K, Kawamoto M et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553\u2013560","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR56_3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/AJP.0b013e318158ed9e","volume":"24","author":"H Knotkova","year":"2008","unstructured":"Knotkova H, Pappagallo M, Szallasi A (2008) Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 24:142\u2013154","journal-title":"Clin J Pain"},{"key":"3_CR57_3","volume-title":"Mechanism and management of headache","author":"J Lance","year":"1969","unstructured":"Lance J (1969) Mechanism and management of headache. Butterworths, New York"},{"key":"3_CR58_3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"3_CR59_3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, Ruhle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277\u20131299","journal-title":"J Comp Neurol"},{"key":"3_CR60_3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.1.3973.431","volume":"194","author":"T Lewis","year":"1937","unstructured":"Lewis T (1937) The nocifensor system of nerves and its reactions. Br Med J 194:431\u2013435","journal-title":"Br Med J"},{"key":"3_CR61_3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0092-8674(00)00143-4","volume":"103","author":"W Liedtke","year":"2000","unstructured":"Liedtke W, Choe Y, Marti-Renom MA et al (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103:525\u2013535","journal-title":"Cell"},{"key":"3_CR62_3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cub.2005.04.018","volume":"15","author":"LJ Macpherson","year":"2005","unstructured":"Macpherson LJ, Geierstanger BH, Viswanath V et al (2005) The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 15:929\u2013934","journal-title":"Curr Biol"},{"key":"3_CR63_3","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1523\/JNEUROSCI.07-12-04129.1987","volume":"7","author":"S Markowitz","year":"1987","unstructured":"Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129\u20134136","journal-title":"J Neurosci"},{"key":"3_CR64_3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature719","volume":"416","author":"DD McKemy","year":"2002","unstructured":"McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:52\u201358","journal-title":"Nature"},{"key":"3_CR65_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","volume":"393","author":"LM McLatchie","year":"1998","unstructured":"McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333\u2013339","journal-title":"Nature"},{"key":"3_CR66_3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/308746a0","volume":"308","author":"HR Morris","year":"1984","unstructured":"Morris HR, Panico M, Etienne T et al (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746\u2013748","journal-title":"Nature"},{"key":"3_CR67_3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF01642901","volume":"238","author":"MA Moskowitz","year":"1991","unstructured":"Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238:S18\u2013S22","journal-title":"J Neurol"},{"key":"3_CR68_3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","volume":"25","author":"PK Mudderry","year":"1988","unstructured":"Mudderry PK, Ghatei MA, Spokes RA et al (1988) Differential expression of [alpha]-CGRP and [beta]-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25:195\u2013205","journal-title":"Neuroscience"},{"key":"3_CR69_3","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1523\/JNEUROSCI.0013-05.2005","volume":"25","author":"K Nagata","year":"2005","unstructured":"Nagata K, Duggan A, Kumar G et al (2005) Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 25:4052\u20134061","journal-title":"J Neurosci"},{"key":"3_CR70_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-2982.2007.01448.x","volume":"28","author":"P Nicoletti","year":"2008","unstructured":"Nicoletti P, Trevisani M, Manconi M et al (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9\u201317","journal-title":"Cephalalgia"},{"key":"3_CR71_3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.00021.2006","volume":"87","author":"B Nilius","year":"2007","unstructured":"Nilius B, Owsianik G, Voets T et al (2007) Transient receptor potential cation channels in disease. Physiol Rev 87:165\u2013217","journal-title":"Physiol Rev"},{"key":"3_CR72_3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/cs0850385","volume":"85","author":"F Njuki","year":"1993","unstructured":"Njuki F, Nicholl CG, Howard A et al (1993) A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 85:385\u2013388","journal-title":"Clin Sci (Lond)"},{"key":"3_CR73_3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104\u20131110","journal-title":"N Engl J Med"},{"key":"3_CR74_3","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1021\/jm070668p","volume":"50","author":"DV Paone","year":"2007","unstructured":"Paone DV, Shaw AW, Nguyen DN et al (2007) Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974). J Med Chem 50:5564\u20135567","journal-title":"J Med Chem"},{"key":"3_CR75_3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(02)00652-9","volume":"108","author":"AM Peier","year":"2002","unstructured":"Peier AM, Moqrich A, Hergarden AC et al (2002) A TRP channel that senses cold stimuli and menthol. Cell 108:705\u2013715","journal-title":"Cell"},{"key":"3_CR76_3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archneurpsyc.1940.02280070051003","volume":"44","author":"W Penfield","year":"1940","unstructured":"Penfield W, McNaughton M (1940) Dural headache and the innervation of the dura mater. Arch Neurol Psychiatr 44:43\u201375","journal-title":"Arch Neurol Psychiatr"},{"key":"3_CR77_3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0021-9258(19)75816-5","volume":"262","author":"J Petermann","year":"1987","unstructured":"Petermann J, Born W, Chang J et al (1987) Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem 262:542\u2013545","journal-title":"J Biol Chem"},{"key":"3_CR78_3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","volume":"25","author":"K Petersen","year":"2005","unstructured":"Petersen K, Birk S, Lassen L et al (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25:139\u2013147","journal-title":"Cephalalgia"},{"key":"3_CR79_3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/35050121","volume":"408","author":"LS Premkumar","year":"2000","unstructured":"Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985\u2013990","journal-title":"Nature"},{"key":"3_CR80_3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb22759.x","volume":"657","author":"R Quirion","year":"1992","unstructured":"Quirion R, D Van Rossum, Dumont Y et al (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88\u2013105","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR81_3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005344-199704000-00006","volume":"29","author":"R Raddino","year":"1997","unstructured":"Raddino R, Pela G, Manca C et al (1997) Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29:463\u2013470","journal-title":"J Cardiovasc Pharmacol"},{"key":"3_CR82_3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1468-2982.2003.00525.x","volume":"23","author":"NM Ramadan","year":"2003","unstructured":"Ramadan NM, Skljarevski V, Phebus LA et al (2003) 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia 23:776\u2013785","journal-title":"Cephalalgia"},{"key":"3_CR83_3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archsurg.1940.01210040002001","volume":"41","author":"B Ray","year":"1940","unstructured":"Ray B, Wolff H (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41:813\u2013856","journal-title":"Arch Surg"},{"key":"3_CR84_3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.107.130344","volume":"324","author":"CA Salvatore","year":"2008","unstructured":"Salvatore CA, Hershey JC, Corcoran HA et al (2008) Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324:416\u2013421","journal-title":"J Pharmacol Exp Ther"},{"key":"3_CR85_3","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/brain\/awn094","volume":"131","author":"GG Schoonman","year":"2008","unstructured":"Schoonman GG, van der Grond J, Kortmann C et al (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation \u2013 a 3T magnetic resonance angiography study. Brain 131:2192\u20132200","journal-title":"Brain"},{"key":"3_CR86_3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-3959(91)90217-L","volume":"47","author":"DA Simone","year":"1991","unstructured":"Simone DA, Ochoa J (1991) Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 47:285\u2013294","journal-title":"Pain"},{"key":"3_CR87_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1468-2982.2002.00378.x","volume":"22","author":"D Smith","year":"2002","unstructured":"Smith D, Hill RG, Edvinsson L et al (2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia 22:424\u2013431","journal-title":"Cephalalgia"},{"key":"3_CR88_3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1703323","volume":"251","author":"RM Snider","year":"1991","unstructured":"Snider RM, Constantine JW, Lowe JA 3rd et al (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435\u2013437","journal-title":"Science"},{"key":"3_CR89_3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0092-8674(03)00158-2","volume":"112","author":"GM Story","year":"2003","unstructured":"Story GM, Peier AM, Reeve AJ et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112:819\u2013829","journal-title":"Cell"},{"key":"3_CR90_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/cs0700389","volume":"70","author":"AD Struthers","year":"1986","unstructured":"Struthers AD, Brown MJ, Macdonald DW et al (1986) Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) 70:389\u2013393","journal-title":"Clin Sci (Lond)"},{"key":"3_CR91_3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","volume":"51","author":"A Szallasi","year":"1999","unstructured":"Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159\u2013212","journal-title":"Pharmacol Rev"},{"key":"3_CR92_3","first-page":"251","volume":"73","author":"J Szolcsanyi","year":"1977","unstructured":"Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol 73:251\u2013259","journal-title":"J Physiol"},{"key":"3_CR93_3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/jpet.106.108316","volume":"319","author":"CK Taylor","year":"2006","unstructured":"Taylor CK, Smith DD, Hulce M et al (2006) Pharmacological characterization of novel alpha-calcitonin gene-related peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors. J Pharmacol Exp Ther 319:749\u2013757","journal-title":"J Pharmacol Exp Ther"},{"key":"3_CR94_3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","volume":"60","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259\u20131287","journal-title":"Drugs"},{"key":"3_CR95_3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1468-2982.1993.1306395.x","volume":"13","author":"LL Thomsen","year":"1993","unstructured":"Thomsen LL, Iversen HK, Brinck TA et al (1993) Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395\u2013399","journal-title":"Cephalalgia"},{"key":"3_CR96_3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","volume":"21","author":"M Tominaga","year":"1998","unstructured":"Tominaga M, Caterina MJ, Malmberg AB et al (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531\u2013543","journal-title":"Neuron"},{"key":"3_CR97_3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nn0602-852","volume":"5","author":"M Trevisani","year":"2002","unstructured":"Trevisani M, Smart D, Gunthorpe MJ et al (2002) Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5:546\u2013551","journal-title":"Nat Neurosci"},{"key":"3_CR98_3","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1007\/s10072-003-0103-5","volume":"24","author":"KMA Welch","year":"2003","unstructured":"Welch KMA (2003) Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets. Neurol Sci 24:S149\u2013S153","journal-title":"Neurol Sci"},{"key":"3_CR99_3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.bjp.0704162","volume":"133","author":"DJ Williamson","year":"2001","unstructured":"Williamson DJ, Hill RG, Shepheard SL et al (2001) The anti-migraine 5-HT(1B\/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol 133:1029\u20131034","journal-title":"Br J Pharmacol"},{"key":"3_CR100_3","first-page":"59","volume-title":"Headache and other head pain","author":"H Wolff","year":"1948","unstructured":"Wolff H (1948) Headache and other head pain. Oxford University Press, New York, pp\u00a059\u201397"},{"key":"3_CR101_3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","volume":"400","author":"PM Zygmunt","year":"1999","unstructured":"Zygmunt PM, Petersson J, Andersson DA et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452\u2013457","journal-title":"Nature"}],"container-title":["Handbook of Experimental Pharmacology","Sensory Nerves"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-79090-7_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:42:03Z","timestamp":1739292123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-79090-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540790891","9783540790907"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-79090-7_3","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}